OVEREXPRESSING CELLULAR REPRESSOR OF E1A-STIMULATED GENES PROTECTS MESENCHYMAL STEM CELLS AGAINST HYPOXIA- AND SERUM DEPRIVATION-INDUCED APOPTOSIS BY ACTIVATION OF PI3K/AKT  by Han, Yaling et al.
A176.E1650
JACC Maarch 9, 2010
Volume 55, issue 10A
 VASCULAR DISEASE
OVEREXPRESSING CELLULAR REPRESSOR OF E1A-STIMULATED GENES PROTECTS MESENCHYMAL 
STEM CELLS AGAINST HYPOXIA- AND SERUM DEPRIVATION-INDUCED APOPTOSIS BY ACTIVATION OF 
PI3K/AKT
ACC Poster Contributions
Georgia World Congress Center, Hall B5
Tuesday, March 16, 2010, 9:30 a.m.-10:30 a.m.
Session Title: Angiogeneis
Abstract Category: Vascular--Pathophysiology--Basic/Angiogenesis/Gene Therapy
Presentation Number: 1275-362
Authors: Yaling Han, Jie Deng, Chenhui Yan, Xiaoxiang Tian, Jie Tao, Jian Kang, Shaohua Li, Shenyang Northern Hospital, Shenyang, People’s 
Republic of China
Background: Bone marrow-derived mesenchymal stem cells (MSCs) hold great potential for repair after myocardial infarction. However, poor 
viability of transplanted MSCs within the ischemic heart has limited their therapeutic potential. Cellular repressor of E1A-stimulated genes(CREG) 
have been revealed as potent inhibitors of apoptosis. The aim of this study was to investigate the anti-apoptotic effects of CREG on MSCs under 
hypoxia and serum deprivation condition.
Methods: Rat bone marrow-derived Mesenchymal stem cells (MSCs) were used as nontransduced (NormMSCs) or transduced with adenoviral-
GFP vector (AdGFPMSCs) or vector encoding for CREG (CREGMSCs). To test the capability of CREG protect against apoptosis in vitro, the MSCs were 
treated under hypoxia/SD conditions for 12 hours. The evaluation of apoptosis was carried out using flow cytometric analysis and TUNEL assay. 
Effects of CREG were investigated in the absence and presence of inhibitors that target phosphoinositide 3-kinase (PI3K).
Results: We demonstrated that overexpressing CREG remarkably prevented MSCs from hypoxia/SD-induced apoptosis through inhibition of the 
mitochondrial apoptotic pathway, leading to attenuation of caspase-3. Moreover, CREG enhanced Akt phosphorylation and decreased expression 
of p53 on MSCs under hypoxia/SD conditions. The PI3K/Akt inhibitor LY294002 significantly increased the amount of p53 protein and attenuated 
anti-apoptotic effects of CREG on MSCs.
Conclusions: These data demonstrate that CREG is a novel, potent survival factor for MSCs, suggesting that it may prove a useful therapeutic 
adjunct for transplanting MSCs into damaged heart after myocardial infarction.
